ADAMIS PHARMACEUTICALS CORP's ticker is ADMP and the CUSIP is 00547W208. A total of 50 filers reported holding ADAMIS PHARMACEUTICALS CORP in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $32,000 | -75.2% | 88,210 | -51.9% | 0.01% | -81.4% |
| Q3 2019 | $129,000 | -75.4% | 183,359 | +82.7% | 0.07% | +105.9% |
| Q3 2017 | $524,000 | +35.8% | 100,378 | +65.2% | 0.03% | +54.5% |
| Q1 2014 | $386,000 | -85.2% | 60,767 | -85.1% | 0.02% | -86.7% |
| Q4 2013 | $2,601,000 | – | 407,024 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Greenlight Capital | 1,000,000 | $1,100,000 | 0.07% |
| Hayden Royal, LLC | 40,015 | $44,000 | 0.02% |
| Verdence Capital Advisors LLC | 143,382 | $158,000 | 0.02% |
| Founders Capital Management | 18,000 | $20,000 | 0.01% |
| WOLFF WIESE MAGANA LLC | 10,740 | $12,000 | 0.01% |
| BALYASNY ASSET MANAGEMENT L.P. | 1,622,510 | $1,785,000 | 0.01% |
| Global Strategic Investment Solutions, LLC | 23,000 | $25,000 | 0.00% |
| Stonebridge Capital Advisors LLC | 44,000 | $45,000 | 0.00% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 100,000 | $110,000 | 0.00% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 97,590 | $107,000 | 0.00% |